The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b, open label, single institution trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors.
 
Ankit Madan
No Relationships to Disclose
 
Benjamin Scott Jones
No Relationships to Disclose
 
Ravi Kumar Paluri
No Relationships to Disclose
 
Mary Jerome
No Relationships to Disclose
 
Debi Miley
No Relationships to Disclose
 
Francisco Robert
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck Sharp & Dohme
Speakers' Bureau - Boehringer Ingelheim; Merck Sharp & Dohme